Terms: = Prostate cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR
17 results:
1. Carboplatin in Metastatic Castrate Resistant prostate cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT).
Pemberton L; Allen C; Handel E; Weickhardt A; Shapiro J; Tran B; Taylor RA; Risbridger GP; Pook DW
Clin Genitourin Cancer; 2024 Apr; 22(2):580-585. PubMed ID: 38402090
[TBL] [Abstract] [Full Text] [Related]
2. Metabolic syndrome-related prognostic index: Predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer.
Ren C; Wang Q; Wang S; Zhou H; Xu M; Li H; Li Y; Chen X; Liu X
Front Endocrinol (Lausanne); 2023; 14():1148117. PubMed ID: 37033267
[TBL] [Abstract] [Full Text] [Related]
3. Regional differences in total hospital costs for radical cystectomy in the United States.
Hoeh B; Flammia RS; Hohenhorst L; Sorce G; Chierigo F; Panunzio A; Tian Z; Saad F; Gallucci M; Briganti A; Terrone C; Shariat SF; Graefen M; Tilki D; Antonelli A; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
Surg Oncol; 2023 Jun; 48():101924. PubMed ID: 36948042
[TBL] [Abstract] [Full Text] [Related]
4. Association between obstructive sleep apnoea and cancer: a cross-sectional, population-based study of the DISCOVERY cohort.
Palm A; Theorell-Haglöw J; Isakson J; Ljunggren M; Sundh J; Ekström MP; Grote L
BMJ Open; 2023 Mar; 13(3):e064501. PubMed ID: 36868588
[TBL] [Abstract] [Full Text] [Related]
5. Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic prostate cancer.
Glicksman RM; Ramotar M; Metser U; Chung PW; Liu Z; Vines D; Finelli A; Hamilton R; Fleshner NE; Perlis N; Zlotta AR; Bayley A; Helou J; Raman S; Kulkarni G; Catton C; Lam T; Chan R; Warde P; Gospodarowicz M; Jaffray DA; Berlin A
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):693-704. PubMed ID: 36031465
[TBL] [Abstract] [Full Text] [Related]
6. Recent Developments in Artificial Intelligence-Based Techniques for prostate cancer Detection: A Scoping Review.
Shah U; Biswas MR; Alzubaidi MS; Ali H; Alam T; Househ M; Shah Z
Stud Health Technol Inform; 2022 Jan; 289():268-271. PubMed ID: 35062144
[TBL] [Abstract] [Full Text] [Related]
7. Stereotactic Body Radiotherapy for Oligometastatic prostate cancer Recurrence: A Meta-analysis.
Viani GA; Arruda CV; Hamamura AC; Faustino AC; Freitas Bendo Danelichen A; Guimarães FS
Am J Clin Oncol; 2020 Feb; 43(2):73-81. PubMed ID: 31809327
[TBL] [Abstract] [Full Text] [Related]
8. Having co-morbid cardiovascular disease at time of cancer diagnosis: already one step behind when it comes to HRQoL?
Schoormans D; Husson O; Oerlemans S; Ezendam N; Mols F
Acta Oncol; 2019 Dec; 58(12):1684-1691. PubMed ID: 31389275
[No Abstract] [Full Text] [Related]
9. prostate cancer screening in the fit Chilean elderly: a head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy.
Murray NP; Reyes E; Orellana N; Fuentealba C; Jacob O
Asian Pac J Cancer Prev; 2015; 16(2):601-6. PubMed ID: 25684494
[TBL] [Abstract] [Full Text] [Related]
10. prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy.
Iremashvili V; Pelaez L; Jordá M; Manoharan M; Rosenberg DL; Soloway MS
Urology; 2012 Nov; 80(5):1063-9. PubMed ID: 23107397
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers.
Cheng TY; Barnett MJ; Kristal AR; Ambrosone CB; King IB; Thornquist MD; Goodman GE; Neuhouser ML
J Nutr; 2011 Sep; 141(9):1731-7. PubMed ID: 21795425
[TBL] [Abstract] [Full Text] [Related]
12. prostate-specific antigen velocity and prostate cancer gleason grade and stage.
Pinsky PF; Andriole G; Crawford ED; Chia D; Kramer BS; Grubb R; Greenlee R; Gohagan JK
Cancer; 2007 Apr; 109(8):1689-95. PubMed ID: 17330856
[TBL] [Abstract] [Full Text] [Related]
13. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").
Bianco FJ; Scardino PT; Eastham JA
Urology; 2005 Nov; 66(5 Suppl):83-94. PubMed ID: 16194712
[TBL] [Abstract] [Full Text] [Related]
14. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy.
D'Amico AV; Desjardin A; Chung A; Chen MH; Schultz D; Whittington R; Malkowicz SB; Wein A; Tomaszewski JE; Renshaw AA; Loughlin K; Richie JP
Cancer; 1998 May; 82(10):1887-96. PubMed ID: 9587121
[TBL] [Abstract] [Full Text] [Related]
16. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
Kawakami M; Nakayama J
Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
[TBL] [Abstract] [Full Text] [Related]
17. [cancer morbidity among alcoholics].
Tønnesen H; Møller H; Andersen JR; Jensen E; Juel K
Ugeskr Laeger; 1995 Feb; 157(9):1199-202. PubMed ID: 7701667
[TBL] [Abstract] [Full Text] [Related]
